Updates in Molluscum Contagiosum Management Digital Edition

Selected Abstracts from Maui Derm 2023 for Dermatologists Digital Edition

Natural Hair Supplements: Trends and Myths Untangled Digital Edition

2022 Conference Highlights: Acne

NP+PA PERSPECTIVES IN DERMATOLOGY

2022 Conference Highlights: Acne

NP+PA Perspectives in Dermatology: March 2023

Special Bonus Issue—Dermatology NP & PA Workforce Survey: Practice Characteristics and Compensation

ALL DIGITAL EDITIONS →

Tag: tofacitinib

New and Emerging Topical Therapies for Psoriasis and Atopic Dermatitis

December 1, 2019

J Clin Aesthet Dermatol. 2019;12(12):28–34 by Corinna E. Psomadakis, MBBS, and George Han, MD Drs. Psomadakis and Han are with the Department of Dermatology, Mount Sinai Medical Center in New

Letters to the Editor: Long-term Treatment with Tofacitinib in Severe Alopecia Areata: An Update

June 1, 2019

Dear Editor: Tofacitinib is a Janus kinase (JAK) 1/3 inhibitor that has been approved by the United States Food and Drug Administration for the treatment of rheumatoid arthritis, psoriatic arthritis,